← Back to Search

Health Communication for HIV/AIDS and Hepatitis C

N/A
Recruiting
Led By Roland C Merchant, MD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study, at 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will assess how a brief persuasive health communication intervention can increase HIV/HCV screening acceptance among ED patients who initially declined. It will compare two delivery forms of this intervention, by a video or HIV/HCV counselor, and assess its efficacy among different injection-drug use history cohorts.

Who is the study for?
This trial is for adults over 18 who speak English or Spanish, have not been tested for HIV/HCV in the past year, and are not currently infected with or being treated for these viruses. It's aimed at those who initially declined testing in the emergency department.
What is being tested?
The study tests a persuasive health communication intervention to increase acceptance of HIV/HCV screening. Participants will be randomly assigned to receive this intervention either through a video or directly from an HIV/HCV counselor.
What are the potential side effects?
Since the interventions involve educational content delivered by video or counselor without medical procedures, there are no direct physical side effects expected from participating in this trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study, at 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study, at 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of patients who accept HIV/HCV testing after speaking with a health educator
Number of patients who accept HIV/HCV testing after watching the video with captions
Number of patients who accept HIV/HCV testing after watching the video without captions
Secondary study objectives
Health economics assessment of PHCI
The number of patients that accept HIV/HCV testing by current injection-drug use
The number of patients that accept HIV/HCV testing by former injection-drug use
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Persuasive Health Communication Intervention delivered in video format with captionsActive Control1 Intervention
A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
Group II: Persuasive Health Communication Intervention delivered in video format without captionsActive Control1 Intervention
A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
Group III: Persuasive Health Communication Intervention delivered by Health EducatorActive Control1 Intervention
Healthcare provider educator getting patients screened for HIV/HCV.

Find a Location

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
903 Previous Clinical Trials
539,768 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,582 Previous Clinical Trials
3,325,040 Total Patients Enrolled
Roland C Merchant, MDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
2 Previous Clinical Trials
1,625 Total Patients Enrolled

Media Library

Persuasive Health Communication Intervention delivered in video format with captions Clinical Trial Eligibility Overview. Trial Name: NCT05968573 — N/A
HIV/AIDS Research Study Groups: Persuasive Health Communication Intervention delivered in video format with captions, Persuasive Health Communication Intervention delivered in video format without captions, Persuasive Health Communication Intervention delivered by Health Educator
HIV/AIDS Clinical Trial 2023: Persuasive Health Communication Intervention delivered in video format with captions Highlights & Side Effects. Trial Name: NCT05968573 — N/A
Persuasive Health Communication Intervention delivered in video format with captions 2023 Treatment Timeline for Medical Study. Trial Name: NCT05968573 — N/A
~1333 spots leftby Dec 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top